Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.53 -0.06 (-1.81%)
As of: Oct 1, 2026 · 10:51 AM EDT

Insight Molecular Diagnostics (IMDX) Other financing activities (2026)

Updated

Insight Molecular Diagnostics' Other financing activities was $23,000 in Q2 2026, down 89.3% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Other financing activities (2026) Analysis & Trends

For FY2025, Other financing activities at Insight Molecular Diagnostics came in at $72,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Insight Molecular Diagnostics 117.12 Mn 40.83 Mn 157,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23,000.00
Mar 31, 2026 214,000.00
API Access

Insight Molecular Diagnostics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IMDX&period=max&api_key=YOUR_API_KEY